M

Metabiomed Co Ltd
KOSDAQ:059210

Watchlist Manager
Metabiomed Co Ltd
KOSDAQ:059210
Watchlist
Price: 4 700 KRW 2.51% Market Closed
Market Cap: ₩132B

Relative Value

The Relative Value of one Metabiomed Co Ltd stock under the Base Case scenario is 5 903.21 KRW. Compared to the current market price of 4 700 KRW, Metabiomed Co Ltd is Undervalued by 20%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
5 903.21 KRW
Undervaluation 20%
Relative Value
Price
M
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
Metabiomed Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Metabiomed Co Ltd
KOSDAQ:059210
132B KRW 1.5 11.5 8.1 12.2
JP
Hoya Corp
TSE:7741
9.3T JPY 10.2 37.2 26.9 32.3
US
Medline Inc
NASDAQ:MDLN
54.8B USD 0 0 0 0
CH
Alcon AG
SIX:ALC
30.1B CHF 3.7 39.2 15.1 29.3
DK
Coloplast A/S
CSE:COLO B
101.8B DKK 3.7 25.7 13.4 16
US
Align Technology Inc
NASDAQ:ALGN
12.1B USD 3 29.5 12.6 17.4
UK
ConvaTec Group PLC
LSE:CTEC
4.6B GBP 2.6 35.5 14.2 24.2
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
41.2B CNY 9.1 25 22.5 22.5
CN
Intco Medical Technology Co Ltd
SZSE:300677
40.5B CNY 4.1 23.8 35.7 35.7
CA
Bausch + Lomb Corp
NYSE:BLCO
5.8B USD 1.1 -16.2 17.2 55.7
JP
Asahi Intecc Co Ltd
TSE:7747
829.7B JPY 6.4 46.9 22.1 30
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett